Jon Golenbiewski

Other News

Request for Applications: see article for details

Lupus Therapeutics Announces a New, Groundbreaking Mechanism to Fund Clinical Studies Addressing the Impact of Diet, Nutrition, and Microbiome on Lupus

New York, NY, November 22, 2024 — The unique IDEAL (Investigate Dietary Approaches for Lupus) Initiative will provide multidisciplinary research teams the...

LRA Spotlight on ACR Convergence 2024: Lupus Therapeutics-Supported Clinical Research and More

New York, NY, November 21, 2024 — New ACR guidelines for advancing the management of lupus nephritis (LN). Novel approaches...

News from ACR Convergence 2024

Lupus Therapeutics Statement on Phase 3 PHOENYCS GO Positive Data In Moderate-To-Severe Systemic Lupus

Washington, DC, November 19, 2024 – Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance (LRA), is encouraged...